News Servier expands global footprint post Shire deal Following its acquisition of Shire’s oncology business in April, Servier is taking steps to expand its presence in the US and China.
News Shire's $2.4bn oncology sell-off seen as Takeda spoiler Move seen as attempt to fend off Takeda takeover
News Safety restrictions spell the end for Servier osteoporosis d... Sales of Protelos hit by safety restrictions.
News Servier and Pfizer begin trials for off-the-shelf T-cell can... Companies hope to challenge traiblazers Novartis and Kite.
News After taking lead in CAR-T, Cellectis drug snapped up by Pfi... Pfizer and Servier have snapped up the rights to UCART19, after the immunotherapy treatment showed hugely encouraging results in a single patient.
News Doctors dismayed by report of NHS AI proposal The British Medical Association has branded a leaked proposal to rein back NHS recruitment and use more AI to compensate a "massive gamble."
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
